GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Stryker Corporation (SYK) [hlAlert]

Rating:
Equal Weight
SYK
down 53.16 %

Stryker Corporation (SYK) rated Equal Weight with price target $58 by Barclays Capital

Posted on: Thursday,  Oct 20, 2011  1:25 PM ET by Barclays Capital

Barclays Capital rated Equal Weight Stryker Corporation (NYSE: SYK) on 10/20/2011. Previously Barclays Capital rated Underweight Stryker Corporation (NYSE: SYK) on
10/21/2009., when the stock price was $47.34. Since then, Stryker Corporation has gained 113.52% as of 01/08/2016's recent price of $101.08.
If you would have followed the previous Barclays Capital's recommendation on SYK, you would have lost 53.16% of your investment in 2270 days.

Stryker Corporation (Stryker) is a medical technology company with a range of products in orthopaedics and a presence in other medical specialties. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose and throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. The Company operates in two business segments: Orthopaedic Implants and MedSurg Equipment. The Orthopaedic Implants segment sells orthopaedic reconstructive (hip, knee and shoulder), trauma, craniomaxillofacial and spinal implant systems; bone cement; and the bone growth factor OP-1. The MedSurg Equipment segment sells surgical equipment; surgical navigation systems; endoscopic, communications and digital imaging systems; as well as patient handling and emergency medical equipment.

Barclays Capital has assembled a world-class, award-winning team of analysts covering, credit, commodities, economics, emerging markets, equities, fixed income, foreign exchange and market strategy. We provide in-depth analysis of companies and macro coverage across asset classes, markets and the world’s economies. We have a highly quantitative approach and our research is underpinned by sophisticated analytics. Combined, these provide clients with the tools and insights necessary for successful risk management and financing. Our research teams are based in many of the world’s major financial centres providing our clients with a globally integrated perspective across products and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/20/2011 1:25 PM Sell
None
48.00 58.00
as of 12/30/2011
1 Week up  0.59 %
1 Month down  -1.80 %
3 Months down  -5.47 %
1 YTD up  7.43 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/16/2010 1:25 PM Sell
None
48.68 50.00
7/15/2010 2:25 PM Sell
None
52.43 59.00
5/14/2010 12:25 PM Sell
None
55.80 62.00
10/21/2009 8:25 AM Sell
None
47.34

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy